Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001437749-24-037745
Filing Date
2024-12-17
Accepted
2024-12-17 17:01:42
Documents
1
Group Members
ANDREW MAZARCHANDLER ROBINSONMICHAEL BROWNTHOMAS O'HALLORAN

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D/A tpllc20241217_sc13da.htm SC 13D/A 94561
  Complete submission text file 0001437749-24-037745.txt   96209
Mailing Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091
Business Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091 8473880349
Monopar Therapeutics (Subject) CIK: 0001645469 (see all company filings)

EIN.: 320463781 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-94081 | Film No.: 241556521
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O SKOKIE BLVD., SUITE 350 WILMETTE IL 60091
Business Address 598 ROCKEFELLER RD. LAKE FOREST IL 60045 4158279929
Tactic Pharma LLC (Filed by) CIK: 0001727357 (see all company filings)

EIN.: 272312444 | State of Incorp.: IL | Fiscal Year End: 1231
Type: SC 13D/A